130 related articles for article (PubMed ID: 11150092)
1. From the food and drug administration.
Henney JE
JAMA; 2001 Jan; 285(1):34. PubMed ID: 11150092
[No Abstract] [Full Text] [Related]
2. FDA approves Trizivir for HIV infection.
AIDS Read; 2000 Dec; 10(12):701. PubMed ID: 11189737
[No Abstract] [Full Text] [Related]
3. Trizivir on the market.
Kerr C
Trends Microbiol; 2001 Jan; 9(1):13. PubMed ID: 11166234
[No Abstract] [Full Text] [Related]
4. AIDS foundation seeks withdrawal of approval for HIV drug combination.
Clarke B
Lancet Infect Dis; 2003 Oct; 3(10):604. PubMed ID: 14558502
[No Abstract] [Full Text] [Related]
5. Anti-HIV agents. Trizivir--three drugs in one pill.
TreatmentUpdate; 2000 Feb; 12(1):1-2. PubMed ID: 12125625
[No Abstract] [Full Text] [Related]
6. Abacavir sulfate, lamivudine, and zidovudine (Trizivir).
Porche D
J Assoc Nurses AIDS Care; 2001; 12(6):88-90. PubMed ID: 11723917
[TBL] [Abstract][Full Text] [Related]
7. Triple-drug tablet approved for HIV infection.
Thompson CA
Am J Health Syst Pharm; 2001 Jan; 58(1):22. PubMed ID: 11194130
[No Abstract] [Full Text] [Related]
8. Effect of co-formulated zidovudine, lamivudine and abacavir (Trizivir) on antiretroviral-naive patients presenting with advanced HIV-1 infection.
Seaton RA; Fox R; Bodasing N; Peters SE; Gourlay Y
AIDS; 2003 Feb; 17(3):445-7. PubMed ID: 12556701
[No Abstract] [Full Text] [Related]
9. Abacavir/lamivudine/zidovudine continues to be a valid and useful antiretroviral regimen.
Shaefer MS
Ann Pharmacother; 2004; 38(7-8):1314-6. PubMed ID: 15187204
[No Abstract] [Full Text] [Related]
10. FDA notifications. Tentative approval given for combination of abacavir, lamivudine & zidovudine tablets.
AIDS Alert; 2009 Sep; 24(9):106. PubMed ID: 19928326
[No Abstract] [Full Text] [Related]
11. AIDS drug in halted trial less effective as monotherapy.
AIDS Read; 2003 Apr; 13(4):159. PubMed ID: 12741364
[No Abstract] [Full Text] [Related]
12. [First HIV triple therapy with one tablet].
Dtsch Med Wochenschr; 2000 Feb; 125(8):A22. PubMed ID: 10723466
[No Abstract] [Full Text] [Related]
13. Lamivudine/zidovudine/abacavir: triple combination tablet.
Ibbotson T; Perry CM
Drugs; 2003; 63(11):1089-98; discussion 1099-1100. PubMed ID: 12749741
[TBL] [Abstract][Full Text] [Related]
14. Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095.
Moyle GJ
AIDS Read; 2003 May; 13(5):223-4, 227, 244. PubMed ID: 12800825
[No Abstract] [Full Text] [Related]
15. Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Shey MS; Kongnyuy EJ; Alobwede SM; Wiysonge CS
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD005481. PubMed ID: 23543540
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
Ruane P; Lang J; DeJesus E; Berger DS; Dretler R; Rodriguez A; Ward DJ; Lim ML; Liao Q; Reddy S; Clair MS; Vila T; Shaefer MS
HIV Clin Trials; 2006; 7(5):229-36. PubMed ID: 17162316
[TBL] [Abstract][Full Text] [Related]
17. New formulations approved for children.
AIDS Patient Care STDS; 2008 Jan; 22(1):88. PubMed ID: 18453043
[No Abstract] [Full Text] [Related]
18. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Trizivir vs. efavirenz: results from ACTG 5095.
Feinberg J
AIDS Clin Care; 2003 Sep; 15(9):78-9. PubMed ID: 14669723
[TBL] [Abstract][Full Text] [Related]
19. [Simplified treatments for HIV infection].
Hirschel B
Ther Umsch; 2004 Oct; 61(10):619-23. PubMed ID: 15532191
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of viral residual replication under maintenance therapy with Trizivir after a quadruple induction regimen in HIV-1-infected adults (Suburbs trial).
de Truchis P; Mathez D; Force G; Rouveix E; Khuong MA; Chemlal K; Thiaux C; Leibowitch J
HIV Clin Trials; 2007; 8(2):102-4. PubMed ID: 17507326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
